Lipid profile and statin use in critical care setting: implications for kidney outcome

• Published in: Einstein (São Paulo, Brazil) Brazil), 2019-05, Vol.17 (3), p.eAO4399-eAO4399
• Main Authors: Malbouisson, Isabelle, Quinto, Beata Marie, Durão Junior, Marcelino de Souza, Monte, Júlio Cesar Martins, Santos, Oscar Fernando Pavão Dos, Narciso, Roberto Camargo, Dalboni, Maria Aparecida, Batista, Marcelo Costa
• Format: Article
• Language: English
• Subjects: C-reactive protein; Hydroxymethylglutaryl-CoA reductase inhibitors; Intensive care units; MEDICINE, GENERAL & INTERNAL; Mortality; Original; Renal replacement therapy
• ISSN: 1679-4508; 2317-6385; 2317-6385
• DOI: 10.31744/einstein_journal/2019AO4399

To determine whether pre-hospital statin use is associated with lower renal replacement therapy requirement and/or death during intensive care unit stay. Prospective cohort analysis. We analyzed 670 patients consecutively admitted to the intensive care unit of an academic tertiary-care hospital. Patients with ages ranging from 18 to 80 years admitted to the intensive care unit within the last 48 hours were included in the study. Mean age was 66±16.1 years old, mean body mass index 26.6±4/9kg/m2 and mean abdominal circumference was of 97±22cm. The statin group comprised 18.2% of patients and had lower renal replacement therapy requirement and/or mortality (OR: 0.41; 95%CI: 0.18-0.93; p=0.03). The statin group also had lower risk of developing sepsis during intensive care unit stay (OR: 0.42; 95%CI: 0.22-0.77; p=0.006) and had a reduction in hospital length-of-stay (14.7±17.5 days versus 22.3±48 days; p=0.006). Statin therapy was associated with a protective role in critical care setting independently of confounding variables, such as gender, age, C-reactive protein, need of mechanical ventilation, use of pressor agents and presence of diabetes and/or coronary disease. Statin therapy prior to hospital admission was associated with lower mortality, lower renal replacement therapy requirement and sepsis rates.